Mori M - Search Results

1

Abnormal expression of TRIB3 in colorectal cancer: a novel marker for prognosis.

Miyoshi N, Ishii H, Mimori K, Takatsuno Y, Kim H, Hirose H, Sekimoto M, Doki Y, Mori M. Miyoshi N, et al. Among authors: mori m. Br J Cancer. 2009 Nov 17;101(10):1664-70. doi: 10.1038/sj.bjc.6605361. Br J Cancer. 2009. PMID: 19904274 Free PMC article.

2

Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: clinical significance.

Iwatsuki M, Mimori K, Ishii H, Yokobori T, Takatsuno Y, Sato T, Toh H, Onoyama I, Nakayama KI, Baba H, Mori M. Iwatsuki M, et al. Among authors: mori m. Int J Cancer. 2010 Apr 15;126(8):1828-1837. doi: 10.1002/ijc.24879. Int J Cancer. 2010. PMID: 19739118

3

RGS16 is a marker for prognosis in colorectal cancer.

Miyoshi N, Ishii H, Sekimoto M, Doki Y, Mori M. Miyoshi N, et al. Among authors: mori m. Ann Surg Oncol. 2009 Dec;16(12):3507-14. doi: 10.1245/s10434-009-0690-3. Epub 2009 Sep 4. Ann Surg Oncol. 2009. PMID: 19760045

4

Notch pathway as candidate therapeutic target in Her2/Neu/ErbB2 receptor-negative breast tumors.

Hirose H, Ishii H, Mimori K, Ohta D, Ohkuma M, Tsujii H, Saito T, Sekimoto M, Doki Y, Mori M. Hirose H, et al. Among authors: mori m. Oncol Rep. 2010 Jan;23(1):35-43. Oncol Rep. 2010. PMID: 19956862

5

TGM2 is a novel marker for prognosis and therapeutic target in colorectal cancer.

Miyoshi N, Ishii H, Mimori K, Tanaka F, Hitora T, Tei M, Sekimoto M, Doki Y, Mori M. Miyoshi N, et al. Among authors: mori m. Ann Surg Oncol. 2010 Apr;17(4):967-72. doi: 10.1245/s10434-009-0865-y. Epub 2009 Dec 22. Ann Surg Oncol. 2010. PMID: 20033322

6

SCRN1 is a novel marker for prognosis in colorectal cancer.

Miyoshi N, Ishii H, Mimori K, Sekimoto M, Doki Y, Mori M. Miyoshi N, et al. Among authors: mori m. J Surg Oncol. 2010 Feb 1;101(2):156-9. doi: 10.1002/jso.21459. J Surg Oncol. 2010. PMID: 20039278

7

ATP11A is a novel predictive marker for metachronous metastasis of colorectal cancer.

Miyoshi N, Ishii H, Mimori K, Tanaka F, Nagai K, Uemura M, Sekimoto M, Doki Y, Mori M. Miyoshi N, et al. Among authors: mori m. Oncol Rep. 2010 Feb;23(2):505-10. Oncol Rep. 2010. PMID: 20043114

8

TDGF1 is a novel predictive marker for metachronous metastasis of colorectal cancer.

Miyoshi N, Ishii H, Mimori K, Sekimoto M, Doki Y, Mori M. Miyoshi N, et al. Among authors: mori m. Int J Oncol. 2010 Mar;36(3):563-8. doi: 10.3892/ijo_00000530. Int J Oncol. 2010. PMID: 20126975

9

Abnormal expression of PFDN4 in colorectal cancer: a novel marker for prognosis.

Miyoshi N, Ishii H, Mimori K, Nishida N, Tokuoka M, Akita H, Sekimoto M, Doki Y, Mori M. Miyoshi N, et al. Among authors: mori m. Ann Surg Oncol. 2010 Nov;17(11):3030-6. doi: 10.1245/s10434-010-1138-5. Epub 2010 Jun 15. Ann Surg Oncol. 2010. PMID: 20552408

10

Jumonji domain containing 1A is a novel prognostic marker for colorectal cancer: in vivo identification from hypoxic tumor cells.

Uemura M, Yamamoto H, Takemasa I, Mimori K, Hemmi H, Mizushima T, Ikeda M, Sekimoto M, Matsuura N, Doki Y, Mori M. Uemura M, et al. Among authors: mori m. Clin Cancer Res. 2010 Sep 15;16(18):4636-46. doi: 10.1158/1078-0432.CCR-10-0407. Epub 2010 Sep 7. Clin Cancer Res. 2010. PMID: 20823141

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,992 results

Search Page

Filters